Menold Daniel

CIK 00017057451 companyNEWARK, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001705745

Recent Transactions

41 trades

Sale
CymaBay Therapeutics, Inc.
Common Stock
2024-01-16$23.58/sh−10,000→ 0 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Common Stock
2024-01-16$4.05/sh+10,000→ 10,000 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-01-16−10,000→ 135,109 total
Sale
CymaBay Therapeutics, Inc.
Common Stock
2023-12-15$21.98/sh−10,000→ 0 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Common Stock
2023-12-15$8.43/sh+11,497→ 11,497 total
Sale
CymaBay Therapeutics, Inc.
Common Stock
2023-12-15$21.99/sh−11,497→ 0 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2023-12-15−11,497→ 0 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2023-12-15−10,000→ 145,109 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Common Stock
2023-12-15$4.05/sh+10,000→ 10,000 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2023-11-15−17,500→ 0 total
Sale
CymaBay Therapeutics, Inc.
Common Stock
2023-11-15$17.38/sh−0→ 0 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Common Stock
2023-11-15$3.45/sh+17,500→ 17,500 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Common Stock
2023-10-16$3.45/sh+17,500→ 17,500 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2023-10-16−17,500→ 17,500 total
Sale
CymaBay Therapeutics, Inc.
Common Stock
2023-10-16$13.76/sh−0→ 0 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Common Stock
2023-09-15$1.72/sh+15,000→ 15,000 total
Sale
CymaBay Therapeutics, Inc.
Common Stock
2023-09-15$16.87/sh−0→ 0 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2023-09-15−15,000→ 0 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2023-09-15−1,545→ 0 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Common Stock
2023-09-15$1.82/sh+1,545→ 1,545 total
Sale
CymaBay Therapeutics, Inc.
Common Stock
2023-09-15$16.87/sh−0→ 0 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Common Stock
2023-08-15$1.06/sh+8,500→ 8,500 total
Sale
CymaBay Therapeutics, Inc.
Common Stock
2023-08-15$11.92/sh−0→ 0 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Common Stock
2023-08-15$10.00/sh+7,000→ 7,000 total
Sale
CymaBay Therapeutics, Inc.
Common Stock
2023-08-15$12.13/sh−0→ 0 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2023-08-15−7,000→ 0 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2023-08-15−8,500→ 0 total
Sale
CymaBay Therapeutics, Inc.
Common Stock
2023-08-09$12.35/sh−20,945→ 0 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Common Stock
2023-08-09$5.00/sh+20,945→ 20,945 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Stock Appreciation Right
2023-08-09−6,486→ 0 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2023-08-09−14,459→ 0 total
Award
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2023-01-25+100,000→ 100,000 total
Award
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2022-01-25+75,000→ 75,000 total
Award
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2021-01-06+42,000→ 42,000 total
Award
CymaBay Therapeutics, Inc.
Stock Option (Right to Buy)
2020-05-15+180,564→ 180,564 total
Award
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2019-01-29+69,156→ 69,156 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Common Stock
2018-08-29$5.00/sh+5,000→ 5,000 total
Exercise/Conversion
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2018-08-29−5,000→ 14,459 total
Sale
CymaBay Therapeutics, Inc.
Common Stock
2018-08-29$13.00/sh−5,000→ 0 total
Award
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2018-01-24+62,500→ 62,500 total
Award
CymaBay Therapeutics, Inc.
Stock Option (right to buy)
2017-05-03+35,000→ 35,000 total

Companies

CymaBay Therapeutics, Inc.
Vice President, Finance

Recent Filings

Address

C/O CYMABAY THERAPEUTICS, INC. 7999 GATEWAY BLVD., SUITE 130

NEWARK, CA, 94560

View on SEC.gov